Implementing community-based provider participation in research: an empirical study.

Implementation Science : IS
Randall TealBryan J Weiner

Abstract

Since 2003, the United States National Institutes of Health (NIH) has sought to restructure the clinical research enterprise in the United States by promoting collaborative research partnerships between academically-based investigators and community-based physicians. By increasing community-based provider participation in research (CBPPR), the NIH seeks to advance the science of discovery by conducting research in clinical settings where most people get their care, and accelerate the translation of research results into everyday clinical practice. Although CBPPR is seen as a promising strategy for promoting the use of evidence-based clinical services in community practice settings, few empirical studies have examined the organizational factors that facilitate or hinder the implementation of CBPPR. The purpose of this study is to explore the organizational start-up and early implementation of CBPPR in community-based practice. We used longitudinal, case study research methods and an organizational model of innovation implementation to theoretically guide our study. Our sample consisted of three community practice settings that recently joined the National Cancer Institute's (NCI) Community Clinical Oncology Program (CCOP) in the...Continue Reading

References

Oct 13, 2001·The Journal of Applied Psychology·K J KleinJ S Sorra
Mar 14, 2003·JAMA : the Journal of the American Medical Association·Nancy S SungDavid Rimoin
Oct 4, 2003·Science·Elias Zerhouni
Sep 22, 2005·JAMA : the Journal of the American Medical Association·Elias A Zerhouni
Jan 25, 2007·JAMA : the Journal of the American Medical Association·John M WestfallLyle Fagnan
May 8, 2007·Journal of Substance Abuse Treatment·Lori J DucharmeJ Aaron Johnson
May 18, 2007·Medical Care Research and Review : MCRR·Christian D HelfrichLori Minasian
May 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J PetrelliKandie Price
Jun 24, 2008·The American Journal of Bioethics : AJOB·Alexander A Kon
Apr 29, 2009·Administration and Policy in Mental Health·J Curtis McMillenVictoria A Osborne
Jul 7, 2009·Journal of Substance Abuse Treatment·Hannah K KnudsenPaul M Roman
Sep 19, 2009·Journal of Health Services Research & Policy·Stephen Buetow
Jan 1, 1994·Qualitative Sociology·Ali ManwarEloise Dunlap
Oct 21, 2009·Implementation Science : IS·Bryan J Weiner
Jan 16, 2010·Journal of the National Cancer Institute·Philip S RosenbergWilliam F Anderson
Feb 26, 2010·Academic Medicine : Journal of the Association of American Medical Colleges·Lyle J FagnanKurt C Stange
Aug 5, 2010·Journal of the National Cancer Institute·John F Scoggins, Scott D Ramsey
Mar 29, 2011·Clinical and Translational Science·Lauren LipiraVictoria Fraser
Apr 6, 2011·Implementation Science : IS·Katherine KahnHarold Pincus
Jul 26, 2011·Implementation Science : IS·Bryan J WeinerMatthew Johnston

❮ Previous
Next ❯

Citations

Apr 20, 2014·Implementation Science : IS·Sara R JacobsAlicia C Bunger
Nov 19, 2015·Implementation Science : IS·Bryan J WeinerSamuel Cykert

❮ Previous
Next ❯

Methods Mentioned

BETA
chip

Software Mentioned

ti
ATLAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.